ACROBiosystems

Where Proteins and Innovation Advance Biomedicine

Biotechnology Research · Delaware

About

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in over 10 different cities within the United States, Switzerland, England and Germany. 🌍Our mission is to accelerate the process of targeted therapeutic drug development. 🤝Our Core Values are Customer-Oriented, Bringing in Values, Confronting Challenges and Enjoy Sharing. 🌱We believe growth is key to unlocking potential.Through continuous learning, clear development paths, professional, personal support, we help members build capabilities and progress. 👏We commit to recognizing employees' unique value.Consistent acknowledgment of efforts builds trust, boosts collaboration, strengthens unity—enabling us to face challenges and succeed with shared purpose. 🏃 Central to our mission is enhancing employee experience—the foundation of belonging.With meaningful work, daily support, wellness, inclusion, we foster value, connection, pride; driving engagement, aligned goals with organizational success, mutual growth. 🧪[European Region] 1. Sales Account Manager - BeneLux Region 2. Marketing Operations Intern (UK, Ireland & Nordics) 🧪[US] 1. Regional Marketing Manager (West Coast, US) 2. Field Application Scientist (CO or TX) 3. Sr. Sales Executive (Multiple Locations)

Details

  • Website: http://www.acrobiosystems.com
  • Founded: 2010
  • Company Size: 194 employees
  • Headquarters: Newark, Delaware
  • Specialties: Proprietary HEK293 expression platform, In-house developed enzymatic and chemical biotin labeling technique, covid-19 antigens and antibodies, CAR-T, Reagents for COVID-19 vaccine development and evaluation, SARS-CoV-2 Related Kit Products, Targets for Antibody-Drug Conjugates, Hot target for bispecific antibody, CD3, Bispecific Antibody, Sars-cov-2 mutants, ADCs, Sars-cov-2 kits, Targets for CAR-T Cell Therapy, Multi-pass Transmembrane Proteins and Technology Platforms, Immune Checkpoint, Cytokine, BsAb targets, Fc Receptors, MABSOL Biotinylated Protein, Enzymes, Anti-idiotypic Antibodies, Cell Gene Therapy, GMP grade Cytokines